Cite
APA Citation
Saxena, A., Engel, A. J., Banbury, B., Hasan, G., Fraser, N., Zaminski, D., Masson, M., Haberman, R. H., Scher, J. U., Ho, G., Law, J., Rackoff, P., Tseng, C., Belmont, H. M., Clancy, R. M., Buyon, J. P., & Izmirly, P. M. (2022). breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City. Lancet, 4, e582–e585. http://access.bl.uk/ark:/81055/vdc_100163059656.0x000005